Logo image of USNA

USANA HEALTH SCIENCES INC (USNA) Stock Price, Forecast & Analysis

USA - NYSE:USNA - US90328M1071 - Common Stock

19.13 USD
-0.03 (-0.16%)
Last: 11/7/2025, 8:24:04 PM
19.13 USD
0 (0%)
After Hours: 11/7/2025, 8:24:04 PM

USNA Key Statistics, Chart & Performance

Key Statistics
Market Cap349.51M
Revenue(TTM)854.50M
Net Income(TTM)34.12M
Shares18.27M
Float10.41M
52 Week High41.84
52 Week Low18.7
Yearly DividendN/A
Dividend YieldN/A
EPS(TTM)1.96
PE9.76
Fwd PE7.21
Earnings (Next)02-23 2026-02-23/amc
IPO1993-10-28
Sector
GICS SectorConsumer Staples
GICS IndustryPersonal Care Products
GICS IndustryGroupHousehold & Personal Products
GICS SubIndustryPersonal Care Products


USNA short term performance overview.The bars show the price performance of USNA in the last week, last 2 weeks, last month, last 3 and 6 months. 1 week 2 week 1 month 3 months 6 months -10 -20 -30

USNA long term performance overview.The bars show the price performance of USNA in the last 1, 2 and 3 years. 1 year 2 years 3 years -20 -40 -60

The current stock price of USNA is 19.13 USD. In the past month the price decreased by -5.58%. In the past year, price decreased by -52.47%.

USANA HEALTH SCIENCES INC / USNA Daily stock chart

USNA Latest News, Press Relases and Analysis

USNA Competitors/Peers

The largest stocks on the US markets in the "Personal Care Products" sub-industry
Full List
Symbol
Company Name
TA
FA
PE
Market Cap
EL ESTEE LAUDER COMPANIES-CL A52.2331.62B
KVUE KENVUE INC15.7832.39B
ELF ELF BEAUTY INC23.864.18B
BRBR BELLRING BRANDS INC13.493.69B
COTY COTY INC-CL A19.743.28B
IPAR INTERPARFUMS INC16.682.81B
EPC EDGEWELL PERSONAL CARE CO7.26870.20M
OLPX OLAPLEX HOLDINGS INC18.33733.79M
NUS NU SKIN ENTERPRISES INC - A6.61451.44M
HNST HONEST CO INC/THE53.3296.53M
NATR NATURES SUNSHINE PRODS INC19.06316.11M
UPXI UPEXI INCN/A194.63M

About USNA

Company Profile

USNA logo image USANA Health Sciences, Inc. develops and manufactures nutritional, personal care and weight-management products. The company is headquartered in Salt Lake City, Utah and currently employs 1,700 full-time employees. Its segments include Direct selling and Hiya direct-to-consumer. The Direct Selling segment develops and manufactures science-based nutritional, personal care and skincare products with a primary focus on promoting long-term health and wellness in various geographic markets worldwide that are distributed through the direct selling channel. The Hiya direct-to-consumer segment is a provider of children’s health and wellness products in the United States that are distributed through the direct-to-consumer channel. Its product line includes USANA Nutritionals Optimizers, Essentials/CellSentials, and Foods. USANA Nutritionals Optimizers products include Proflavanol, CoQuinone 30, and BiOmega-3. Essentials/CellSentials products include USANA CellSentials and HealthPak 100.

Company Info

USANA HEALTH SCIENCES INC

3838 West Parkway Blvd.

Salt Lake City UTAH 84120 US

CEO: Kevin G. Guest

Employees: 1700

USNA Company Website

USNA Investor Relations

Phone: 18019547100

USANA HEALTH SCIENCES INC / USNA FAQ

What does USNA do?

USANA Health Sciences, Inc. develops and manufactures nutritional, personal care and weight-management products. The company is headquartered in Salt Lake City, Utah and currently employs 1,700 full-time employees. Its segments include Direct selling and Hiya direct-to-consumer. The Direct Selling segment develops and manufactures science-based nutritional, personal care and skincare products with a primary focus on promoting long-term health and wellness in various geographic markets worldwide that are distributed through the direct selling channel. The Hiya direct-to-consumer segment is a provider of children’s health and wellness products in the United States that are distributed through the direct-to-consumer channel. Its product line includes USANA Nutritionals Optimizers, Essentials/CellSentials, and Foods. USANA Nutritionals Optimizers products include Proflavanol, CoQuinone 30, and BiOmega-3. Essentials/CellSentials products include USANA CellSentials and HealthPak 100.


What is the current price of USNA stock?

The current stock price of USNA is 19.13 USD. The price decreased by -0.16% in the last trading session.


What is the dividend status of USANA HEALTH SCIENCES INC?

USNA does not pay a dividend.


What is the ChartMill technical and fundamental rating of USNA stock?

USNA has a ChartMill Technical rating of 0 out of 10 and a ChartMill Fundamental rating of 5 out of 10.


Is USANA HEALTH SCIENCES INC (USNA) expected to grow?

The Revenue of USANA HEALTH SCIENCES INC (USNA) is expected to grow by 8.22% in the next year. Check the estimates tab for more information on the EPS, Sales, EBIT and EBITDA future analyst estimates.


What is the market capitalization of USNA stock?

USANA HEALTH SCIENCES INC (USNA) has a market capitalization of 349.51M USD. This makes USNA a Small Cap stock.


Can you provide the upcoming earnings date for USANA HEALTH SCIENCES INC?

USANA HEALTH SCIENCES INC (USNA) will report earnings on 2026-02-23, after the market close.


USNA Technical Analysis


Chartmill TA Rating
Chartmill Setup Rating

USNA Fundamental Analysis

ChartMill assigns a fundamental rating of 5 / 10 to USNA. While USNA has a great health rating, its profitability is only average at the moment.


Chartmill FA Analysis
Valuation
Growth
Profitability
Health
Dividend

USNA Financial Highlights

Over the last trailing twelve months USNA reported a non-GAAP Earnings per Share(EPS) of 1.96. The EPS decreased by -30.74% compared to the year before.


Industry RankSector Rank
PM (TTM) 3.79%
ROA 4.64%
ROE 6.42%
Debt/Equity 0
Chartmill High Growth Momentum
EPS Q2Q%-126.79%
Sales Q2Q%6.88%
EPS 1Y (TTM)-30.74%
Revenue 1Y (TTM)-7.22%

USNA Forecast & Estimates

6 analysts have analysed USNA and the average price target is 39.78 USD. This implies a price increase of 107.95% is expected in the next year compared to the current price of 19.13.

For the next year, analysts expect an EPS growth of -33.31% and a revenue growth 8.22% for USNA


Analysts
Analysts43.33
Price Target39.78 (107.95%)
EPS Next Y-33.31%
Revenue Next Year8.22%

USNA Ownership

Ownership
Inst Owners61.34%
Ins Owners0.61%
Short Float %7.2%
Short Ratio4.54